Pfizer Pharma GmbH

Profile
More about Pfizer
  • News

    Anokion Announces $35 Million Equity Investment from Pfizer

    Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, announced that Pfizer has made a $35 million equity investment in Anokion through the Pfizer Breakthrough Growth Initiative. In conjunction with the investment, Mi ... more

    Pfizer will invest €90.5 million in Valneva

    Valneva SE and Pfizer Inc. announced that they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and License Agreement for Lyme disease vaccine candidate VLA15. As previously announced on April 26, 2022, Pfizer plans to initiate the Phase 3 ... more

    Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program

    Pfizer Inc. announced that the first participants have been dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of a single dose quadrivalent mRNA vaccine against influenza in healthy adults. Pfizer’s mRNA influenza vaccine program is the first in a pl ... more

  • Companies

    Pfizer Pharma GmbH

    more

    Pfizer Corporation Austria Ges. m.b.H.

    Helping people to a healthier and longer life with a higher quality of life is the aim of Pfizer . Under the motto " Working together for a healthier world TM ", more than 97,000 employees worldwide are working to achieve this goal. They are researching, developing and marketing drugs and v ... more

    Pfizer Inc.

    Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging mar ... more